Opinion: Good, But Not Good Enough

Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.

Written byUmberto Galderisi
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

FLICKR, IMAGES_OF_MONEY

The system for funding scientific research is broken.

This declaration came to my mind after I experienced three separate occurrences. The first was my application for a European research grant. At the end of the evaluation procedure, the reviewers wrote that my proposal was interesting, I had a good track record of publications, and the project had been well described. Nevertheless, they had to reject my application since I am a “good” but not “outstanding” researcher. This reply was received after I had applied for dozens of research grants without success.

My reading of a comment by John P. A. Ioannidis in Nature (477,529–531 2011) was the second occurrence. He wrote: “...the research behind 30 percent of the pivotal papers from Nobel Laureates in medicine, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies